|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, September 17, 2016 ) Technavio Announces the Publication of its Research Report Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020
Technavio recognizes the following companies as the key players in the global non-invasive prenatal testing (NIPT) market: BGI Genomics, Illumina, LifeCodexx, Natera, and Sequenom.
Other Prominent Vendors in the market are: Ariosa Diagnostics, Berry Genomics, CombiMatrix, F. Hoffmann-La Roche, Genpharm Services, Laboratory Corporation of America Holdings, LifeLabs Genetics, Quest Diagnostics, Safembryo, and Sengenics.
Browse full report with TOC@ https://marketreportscenter.com/reports/383375/global-non-invasive-prenatal-testing-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Increase in partnerships and collaborations will be a challenge for the market. Vendors enter into partnerships and collaborations to extend their product offerings, increase their market shares, and expand their operations. These partnerships and collaborations help vendors enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. For instance, in 2015, Human Longevity entered into a partnership with Roche Diagnostics to conduct whole-genome sequencing of Roche Diagnostics' subsidiary Genentech's de-identified samples. The partnership helped Roche Diagnostics analyze patient samples based on precise genetic categories and discover new diagnostics and targeted therapies. In 2011, Natera formed a partnership with DNA Diagnostics Center to enter the market. These partnerships and collaborative activities are accelerating drug discovery efforts, which will lead to the development of new therapies to detect chromosomal abnormalities in neonates.”
According to the report, the number of neonates with chromosomal disorders is on the rise worldwide due to rapid urbanization, child-bearing at an advanced maternal age, pollution, and increased consumption of alcohol consumption. This factor will be a key driver for market growth. A few conventional procedures such as chorionic villus sampling and amniocentesis that help detect chromosomal defects in developing fetuses are available in the market. However, these tests have high chances of causing miscarriage, restricting people from undergoing them. This unmet need led to the development of new advanced prenatal tests that are invasive and have no risks of miscarriage. Vendors are also developing NIPTs that have high accuracy result and lower side effects for use in hospitals and nursing homes.
Further, the report states that limited consumer options and lack of effective product differentiation will be a challenge for the market. The market presents significant opportunities for vendors to expand and increase their profit margins. The standard economic equilibrium theory states that markets with high-profit margins attract new competitors. The intense competition is largely based on clinical results and designs of the products. Most vendors have similar product offerings, which limit the options for consumers. This has led many companies, particularly the leading vendors, to operate on low-profit margins, which will persist during the forecast period as well. If this situation continues, leading vendors will face difficulties in surviving in the market.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/383375
About NIPT
NIPT is an advanced technology that helps detect fatal chromosomal aneuploidies by analyzing the fetus' cell-free DNA. It also helps diagnose the risks for genetic disorders such as Down, Turner, Klinefelter, and XYY syndromes, which are common sex chromosomal aneuploidies associated with reproductive loss, infertility, and language development delays. Since its introduction into clinical practice in Hong Kong in 2011, NIPT has rapidly spread across the world.
Technavios analysts forecast the global non-invasive prenatal testing (NIPT) market to grow at a CAGR of 17.44% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global non-invasive prenatal testing (NIPT) market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of testing products.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio's report, Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/383375
Connect for more details:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
info@marketreportscenter.com
Market Reports Center
Sam Collins
1-646-883-3044
sam@marketreportscenter.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
